DOMANTIS LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 21234
 
  
 
C07K PEPTIDES 18118
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 220
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0299,321 COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USEJun 16, 15Oct 22, 15[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9908937 Compositions monovalent for CD28 binding and methods of useJun 16, 15Mar 06, 18[A61K, C07K]
9765150 Antibody polypeptides that antagonize CD40LNov 24, 15Sep 19, 17[A61K, C07K]
9629909 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissueJun 18, 13Apr 25, 17[A61K, C07K]
9562090 Polypeptides, antibody variable domains and antagonistsFeb 11, 13Feb 07, 17[A61K, C07K, A61M]
9475879 Antibody polypeptides that antagonize CD40Apr 20, 12Oct 25, 16[A61K, C07K]
9321832 LigandFeb 08, 07Apr 26, 16[C12P, C07K]
9228018 Antibody polypeptides that antagonize CD40LOct 09, 14Jan 05, 16[A61K, C07K]
9085629 Compositions monovalent for CD28 binding and methods of useMar 09, 12Jul 21, 15[C07K]
9028822 Antagonists against TNFR1 and methods of use thereforJul 13, 11May 12, 15[A61K, C07K]
8981072 Nucleic acids encoding antibody polypeptides that antagonize CD40LDec 10, 13Mar 17, 15[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0087,813 LIGANDAbandonedFeb 05, 14Mar 26, 15[C07K]
2015/0064,185 DRUG COMPOSITIONS, FUSHIONS AND CONJUGATESAbandonedNov 13, 14Mar 05, 15[C07K]
2014/0341,971 COMPOSITION FOR TARGETING DENDRITIC CELLSAbandonedJun 20, 14Nov 20, 14[A61K]
2013/0230,540 COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USEAbandonedJul 10, 12Sep 05, 13[C07K]
2013/0216,538 Compositions and Methods for Treating Inflammatory DisordersAbandonedJan 03, 13Aug 22, 13[C07K]
2013/0041,136 LIGANDS THAT HAVE BINDING SPECIFICITY FOR EGFR AND/OR VEGF AND METHODS OF USE THEREFORAbandonedOct 26, 12Feb 14, 13[C07K]
8084213 SelectionExpiredJan 17, 07Dec 27, 11[A61K, C07H, C12Q, C12P, C12N, C07K]
2011/0172,400 COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USEAbandonedNov 08, 10Jul 14, 11[C07K]
2011/0159,003 Ligands That Bind Il-4 and/or Il-13AbandonedJan 24, 07Jun 30, 11[A61K, C12P, C12N, A61P, C07K]
2011/0097,339 Compositions monovalent for CD28 binding and methods of useAbandonedJun 18, 09Apr 28, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0086,019 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FORAbandonedJun 03, 08Apr 14, 11[A61K, A61P, C07K]
7846721 GAS1 universal leaderExpiredJul 27, 06Dec 07, 10[C07H, C12Q, C12N]
2010/0254,972 METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDESAbandonedJun 03, 08Oct 07, 10[A61K, C12N, A61P, C07K]
2010/0254,995 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSAbandonedJun 03, 08Oct 07, 10[A61K, A61P, C07K]
2010/0247,515 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSAbandonedJun 04, 08Sep 30, 10[A61K, A61P, C07K]
2010/0234,570 LigandAbandonedAug 08, 06Sep 16, 10[C07K]
2010/0168,393 Antibody Polypeptide Libray Screening and Selected Antibody PolypeptidesAbandonedOct 11, 06Jul 01, 10[C40B, C07K]
2010/0143,371 INTRABODIESAbandonedOct 31, 07Jun 10, 10[A61K, C12N, A61P, C07K]
7696320 Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforExpiredJan 11, 06Apr 13, 10[C12P]
2010/0081,792 LigandAbandonedOct 31, 07Apr 01, 10[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.